Insider Transactions Reported by 22 Insiders of Climb Bio, Inc.

Symbol
CLYM on Nasdaq
Location
Wellesley Hills, MA

Insiders trading volume in the past year

Climb Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
AI ETI LLC 10%+ Owner $62,617,500 12 Aug 2021
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $11,912,001 +$779,626 +7% 05 Jan 2026
Aoife Brennan President and CEO, Director $2,042,709 -$25,154 -1.2% 06 Jan 2026
Stephen Basil Thomas Director $1,116,399 -$879,382 -44% 25 Feb 2026
Brett Kaplan Chief Operating Officer $618,450 13 Jan 2025
Valerie Morisset Evp, R&D And Cso $249,910 19 Jul 2024
Emily Pimblett SVP, Finance & CAO $63,821 -$3,111 -4.6% 18 Jun 2025
Susan Altschuller Chief Financial Officer 06 Jan 2026
Perrin Megan Wilson Chief Business Officer 06 Jan 2026
Douglas E. Williams Director 04 Jun 2025
Kimberlee C. Drapkin Director 04 Jun 2025
Judith Dunn Director 04 Jun 2025
Andrew David Levin Director 04 Jun 2025
Cindy Driscoll Senior Vice President, Finance 06 Jan 2026
Alexander Cumbo Director 04 Jun 2025
Leone D. Patterson Director 19 May 2022
Robert Azelby President & CEO, Director 31 Oct 2022
Liam Ratcliffe Director 26 Jun 2024
James B. Bucher EVP and General Counsel 31 Oct 2022
Simon Tate Director 26 Jun 2024
Adam Joseph Rosenberg Director 26 Jun 2024
Erin Lavelle Coo & Cfo 31 Oct 2022

Recent Insider Transactions by Companies or Individuals for Climb Bio, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Stephen Basil Thomas CLYM Common Stock Sale -9.54% $114,289 $7.01 -16,313 154,657 26 Feb 2026 Direct
Stephen Basil Thomas CLYM Common Stock Sale -16.5% $235,964 $7.00 -33,687 170,970 25 Feb 2026 Direct
Stephen Basil Thomas CLYM Common Stock Sale -4.66% $58,141 $5.81 -10,000 204,657 13 Feb 2026 Direct
Stephen Basil Thomas CLYM Common Stock Sale -29.5% $470,988 $5.23 -90,000 214,657 12 Feb 2026 Direct
Aoife Brennan CLYM Stock Option (Right to Buy) Award 700,000 700,000 06 Jan 2026 Direct
Perrin Megan Wilson CLYM Stock Option (Right to Buy) Award 300,000 300,000 06 Jan 2026 Direct
Susan Altschuller CLYM Stock Option (Right to Buy) Award 142,500 142,500 06 Jan 2026 Direct
Cindy Driscoll CLYM Stock Option (Right to Buy) Award 100,000 100,000 06 Jan 2026 Direct
Ra Capital Management, L.P. CLYM Common Stock Purchase 0.21% $24,888 $3.50 7,111 3,403,429 05 Jan 2026 See footnotes
Ra Capital Management, L.P. CLYM Common Stock Purchase 3.08% $290,181 $2.86 101,462 3,396,318 12 Dec 2025 See footnotes
Ra Capital Management, L.P. CLYM Common Stock Purchase 6.91% $464,556 $2.18 213,099 3,294,856 11 Dec 2025 See footnotes
Ra Capital Management, L.P. CLYM Common Stock Disposed to Issuer -86.9% -20,440,000 3,081,757 11 Dec 2025 See footnotes
Ra Capital Management, L.P. CLYM Pre-Funded Warrants (Right to Buy) Award 20,440,000 20,440,000 11 Dec 2025 See footnotes
Susan Altschuller CLYM Stock Option (Right to Buy) Award 600,000 600,000 01 Oct 2025 Direct
Stephen Basil Thomas CLYM Common Stock Award 49.1% 100,375 304,657 07 Aug 2025 Direct
Aoife Brennan CLYM Common Stock Sale -30% $25,154 $1.22 -20,618 48,132 30 Jun 2025 Direct
Aoife Brennan CLYM Common Stock Options Exercise 68,750 68,750 27 Jun 2025 Direct
Aoife Brennan CLYM Restricted Stock Units Options Exercise -25% -68,750 206,250 27 Jun 2025 Direct
Stephen Basil Thomas CLYM Common Stock Options Exercise 14% 25,094 204,282 27 Jun 2025 Direct
Stephen Basil Thomas CLYM Restricted Stock Units Options Exercise -100% -25,094 0 27 Jun 2025 Direct
Emily Pimblett CLYM Common Stock Sale -6.17% $1,540 $1.24 -1,242 18,888 20 Jun 2025 Direct
Emily Pimblett CLYM Common Stock Options Exercise 33% 5,000 20,130 18 Jun 2025 Direct
Emily Pimblett CLYM Restricted Stock Units Options Exercise -25% -5,000 15,000 18 Jun 2025 Direct
Cindy Driscoll CLYM Stock Option (Right to Buy) Award 200,000 200,000 17 Jun 2025 Direct
Ra Capital Management, L.P. CLYM Stock Option (Right to Buy) Award 40,000 40,000 04 Jun 2025 See Footnotes
Kimberlee C. Drapkin CLYM Stock Option (Right to Buy) Award 40,000 40,000 04 Jun 2025 Direct
Alexander Cumbo CLYM Stock Option (Right to Buy) Award 40,000 40,000 04 Jun 2025 Direct
Judith Dunn CLYM Stock Option (Right to Buy) Award 40,000 40,000 04 Jun 2025 Direct
Douglas E. Williams CLYM Stock Option (Right to Buy) Award 40,000 40,000 04 Jun 2025 Direct
Andrew David Levin CLYM Stock Option (Right to Buy) Award 40,000 40,000 04 Jun 2025 Direct
Stephen Basil Thomas CLYM Stock Option (Right to Buy) Award 40,000 40,000 04 Jun 2025 Direct
Douglas E. Williams CLYM Stock Option (Right to Buy) Award 78,873 78,873 31 Mar 2025 Direct
Kimberlee C. Drapkin CLYM Stock Option (Right to Buy) Award 80,000 80,000 28 Mar 2025 Direct
Alexander Cumbo CLYM Stock Option (Right to Buy) Award 80,000 80,000 28 Mar 2025 Direct
Stephen Basil Thomas CLYM Common Stock Options Exercise 16.3% 25,093 179,188 27 Mar 2025 Direct
Stephen Basil Thomas CLYM Restricted Stock Units Options Exercise -50% -25,093 25,094 27 Mar 2025 Direct
Emily Pimblett CLYM Common Stock Sale -7.34% $1,571 $1.31 -1,199 15,130 20 Mar 2025 Direct
Emily Pimblett CLYM Common Stock Options Exercise 44.1% 5,000 16,329 18 Mar 2025 Direct
Emily Pimblett CLYM Restricted Stock Units Options Exercise -20% -5,000 20,000 18 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.